Literature DB >> 12832002

Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats.

Gabriel Nowak1, Bernadeta Szewczyk, Joanna M Wieronska, Piotr Branski, Agnieszka Palucha, Andrzej Pilc, Krystyna Sadlik, Wojciech Piekoszewski.   

Abstract

The activity of zinc administered intraperitoneally, acutely (in single dose), sub-chronically (in triple doses) or chronically (once daily for 14 days) were assessed in the forced swim test (FST) and olfactory bulbectomy (OB) model of depression in rats. Previously, we have demonstrated that acute administration of zinc sulfate is active in FST in rats and mice. In the present study, zinc hydroaspartate in a dose of 65 mg/kg (11.5 mgZn/kg), all: acute, sub-chronic and chronic administration, reduced the immobility time in the FST in rats. Removal of olfactory bulbs (OB surgery) in rats is associated with variety of behavioral abnormalities such as deficit in a step-down passive avoidance or hyperactivity in the "open field" test. Both acute and chronic administration of zinc hydroaspartate reduced the number of trials needed to the learning passive avoidance and reduced the OB-induced hyperactivity in rats. At the time schedule following zinc hydroaspartate administration, when behavioral experiments were performed, the serum zinc concentrations were significantly higher than control-physiological values. These results confirm activity of zinc in the FST, show its antidepressant-like activity in the OB rat model of depression, demonstrate the lack of tolerance to these effects and suggest relationship of these antidepressant-like effects with the rise in serum zinc. These animal data further suggest antidepressant activity of zinc in human depression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12832002     DOI: 10.1016/s0361-9230(03)00104-7

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  28 in total

1.  Thymoquinone loaded solid lipid nanoparticles counteracts 3-Nitropropionic acid induced motor impairments and neuroinflammation in rat model of Huntington's disease.

Authors:  Surekha Ramachandran; Sumathi Thangarajan
Journal:  Metab Brain Dis       Date:  2018-05-31       Impact factor: 3.584

Review 2.  The Role of Nutrients in Protecting Mitochondrial Function and Neurotransmitter Signaling: Implications for the Treatment of Depression, PTSD, and Suicidal Behaviors.

Authors:  Jing Du; Ming Zhu; Hongkun Bao; Bai Li; Yilong Dong; Chunjie Xiao; Grace Y Zhang; Ioline Henter; Matthew Rudorfer; Benedetto Vitiello
Journal:  Crit Rev Food Sci Nutr       Date:  2016-11-17       Impact factor: 11.176

3.  Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington's disease model in rats.

Authors:  Sarumani Natarajan Suganya; Thangarajan Sumathi
Journal:  Metab Brain Dis       Date:  2016-12-08       Impact factor: 3.584

4.  Brain-Delivery of Zinc-Ions as Potential Treatment for Neurological Diseases: Mini Review.

Authors:  Andreas M Grabrucker; Magali Rowan; Craig C Garner
Journal:  Drug Deliv Lett       Date:  2011-09

5.  Peripheral zinc and neopterin concentrations are associated with mood severity in bipolar disorder in a gender-specific manner.

Authors:  Caitlin E Millett; Dahlia Mukherjee; Aubrey Reider; Adem Can; Maureen Groer; Dietmar Fuchs; Teodor T Postolache; Shannon L Kelleher; Erika F H Saunders
Journal:  Psychiatry Res       Date:  2017-05-17       Impact factor: 3.222

6.  Antidepressant-like effects of nicotine and transcranial magnetic stimulation in the olfactory bulbectomy rat model of depression.

Authors:  Patricia Vieyra-Reyes; Yann S Mineur; Marina R Picciotto; Isaac Túnez; Román Vidaltamayo; René Drucker-Colín
Journal:  Brain Res Bull       Date:  2008-06-26       Impact factor: 4.077

Review 7.  Improving treatments and outcomes: an emerging role for zinc in traumatic brain injury.

Authors:  Elise C Cope; Deborah R Morris; Cathy W Levenson
Journal:  Nutr Rev       Date:  2012-05-22       Impact factor: 7.110

8.  Antidepressant-like activity of zinc: further behavioral and molecular evidence.

Authors:  Magdalena Sowa-Kućma; Beata Legutko; Bernadeta Szewczyk; Kinga Novak; Paweł Znojek; Ewa Poleszak; Mariusz Papp; Andrzej Pilc; Gabriel Nowak
Journal:  J Neural Transm (Vienna)       Date:  2008-09-03       Impact factor: 3.575

9.  Involvement of glutamatergic neurotransmission in the antidepressant-like effect of zinc in the chronic unpredictable stress model of depression.

Authors:  Luana M Manosso; Morgana Moretti; André R Colla; Camille M Ribeiro; Tharine Dal-Cim; Carla I Tasca; Ana Lúcia S Rodrigues
Journal:  J Neural Transm (Vienna)       Date:  2016-01-08       Impact factor: 3.575

10.  Use of zinc as a treatment for traumatic brain injury in the rat: effects on cognitive and behavioral outcomes.

Authors:  Elise C Cope; Deborah R Morris; Angus G Scrimgeour; Cathy W Levenson
Journal:  Neurorehabil Neural Repair       Date:  2012-02-13       Impact factor: 3.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.